CD8A and metabolic dysfunction-associated steatohepatitis: Therefore, similarly to what observed in murine models, it could be speculated that also in patients with NASH exists an interaction between CD8+ T cells, NKT cells, their secreted cytokines and hepatocytes, thus suggesting that targeting specific immune signaling pathways could potentially diminish the risk to develop liver damage and progression to HCC.